InsidersTradesSigma
Follow the APOGEE THERAPEUTICS INC stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €10.2bn. The latest transaction was reported on 1 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: CARL DAMBKOWSKI. Every trade is free.
Analysts rate APOGEE THERAPEUTICS INC Hold (neutral), based on 11 analysts. Average price target: US$134.85.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
APOGEE THERAPEUTICS INC 是一家专注于开发创新治疗方法的公司。它在纳斯达克上市，股票代码为XNAS。